4//SEC Filing
Waldegrave William A. 4
Accession 0000899243-19-019501
CIK 0001351288other
Filed
Jul 10, 8:00 PM ET
Accepted
Jul 11, 9:00 PM ET
Size
9.5 KB
Accession
0000899243-19-019501
Insider Transaction Report
Form 4
Waldegrave William A.
Director
Transactions
- Sale
Ordinary Shares
2019-07-10$15.00/sh−3,576$53,640→ 0 total - Exercise/Conversion
Ordinary Shares
2019-07-10$0.00/sh+3,576$5→ 3,576 total - Exercise/Conversion
Stock Options
2019-07-10−3,576→ 7,164 totalExercise: $0.00From: 2019-01-03Exp: 2028-01-03→ Ordinary Shares (3,576 underlying)
Footnotes (5)
- [F1]Exercise of stock options. Following the exercise, these shares were converted into American Depositary Shares ("ADS") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer.
- [F2]Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.25 U.S. Dollars as of July 10, 2019.
- [F3]Represented by ADSs. The sales reported were effected pursuant to a Rule 10b-5 trading plan adopted by the Reporting Person on May 10, 2019.
- [F4]The price reported in Column 4 is price per ordinary share converted from price per ADS.
- [F5]The reporting person's Form 3 filed on October 1, 2018 contained stock options to purchase 10,740 ordinary shares vesting on January 3, 2021 and expiring on January 3, 2028. The correct vesting schedules for these securities are: 3,680 ordinary shares have vested on January 3, 2019, and the rest will vest equally on January 3, 2020 and January 3, 2021.
Documents
Issuer
GW PHARMACEUTICALS PLC
CIK 0001351288
Entity typeother
Related Parties
1- filerCIK 0001754145
Filing Metadata
- Form type
- 4
- Filed
- Jul 10, 8:00 PM ET
- Accepted
- Jul 11, 9:00 PM ET
- Size
- 9.5 KB